Long-term outcome of Kawasaki disease

Circulation

Volumn 118, Issue 25, 2008, Pages 2763-2772

  Senzaki, Hideaki ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiography; Coronary disease; Risk factors

Indexed keywords

ABCIXIMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; INFLIXIMAB; METHYLPREDNISOLONE; PENTOXIFYLLINE; ULINASTATIN;

ARTICLE; CLINICAL FEATURE; COLLATERAL CIRCULATION; CORONARY ARTERY; ECHOCARDIOGRAPHY; FOLLOW UP; GENETIC SUSCEPTIBILITY; HEREDITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTRAVASCULAR ULTRASOUND; JAPAN; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE DRUG DOSE; UNITED KINGDOM; UNITED STATES;

ANIMALS; CORONARY VESSELS; GAMMA-GLOBINS; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME; TIME; TREATMENT OUTCOME;

EID: 58249126971     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.749515     Document Type: Article

References (151)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children (in Japanese). Arerugi. 1967;16:178-222.
2. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975;86:892-898.
3. Burns JC. Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967. Pediatr Infect Dis J. 2002;21:993-1005.
4. Burns JC. Kawasaki syndrome. Lancet. 2004;364:533-544.
5. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Palace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747-2771.
6. Kim DS. Kawasaki disease. Yonsei Med J. 2006;47:759-772.
7. Yanagawa H, Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K. Incidence of Kawasaki disease in Japan: the nationwide surveys of 1999-2002. Pediatr Int. 2006;48:356-361.
8. Holman RC, Curns AT, Belay ED, Steiner CA, Effler PV, Yorita KL, Miyamura J, Forbes S, Schonberger LB, Melish M. Kawasaki syndrome in Hawaii. Pediatr Infect Dis J. 2005;429-433.
9. Chang RK. The incidence of Kawasaki disease in the United States did not increase between 1988 and 1997. Pediatrics. 2003;111:1124-1125.
10. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003;112:495-501.
11. Park YW, Han JW, Park IS, Kim CH, Cha SH, Ma JS, Lee JS, Kwon TC, Lee SB, Kim CH, Lee HJ, Yun YS. Kawasaki disease in Korea, 2003-2005. Pediatr Infect Dis J. 2007;26:821-823.
12. Harnden A, Alves B, Sheikh A. Rising incidence of Kawasaki disease in England: analysis of hospital admission data. BMJ. 2002;324:1424-1425.
13. Royle JA, Williams K, Elliott E, Sholler G, Nolan T, Allen R, Isaacs D. Kawasaki disease in Australia, 1993-95. Arch Dis Child. 1998;78:33-39.
14. Carman PG, Menahem S. Possible "outbreak" of Kawasaki disease in Victoria. Med J Aust. 1983;2:183-185.
15. Yanagawa H, Nakamura Y, Ojima T, Yashiro M, Tanihara S, Oki I. Changes in epidemic patterns of Kawasaki disease in Japan. Pediatr Infect Dis J. 1999;18:64-66.
16. Dean AG, Melish ME, Hicks R, Palumbo NE. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr. 1982;100:552-557.
17. Bell DM, Brink EW, Nitzkin JL, Hall CB, Wulff H, Berkowitz ID, Feorino PM, Holman RC, Huntley CL, Meade RH III, Anderson LJ, Cheeseman SH, Fiumara NJ, Gilfillan RF, Keim DE, Modlin JF. Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med. 1981;304:1568-1575.
18. Lee DB. Epidemiologic study of Kawasaki disease in Korea. Prog Clin Biol Res. 1987;250:55-60.
19. Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Tanihara S, Oki I, Zhang T. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics. 1998;102:E65.
20. Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr. 2001;90:40-44.
21. Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease in parents and children. Acta Paediatr. 2003;92:694-697.
22. Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, Nagai M, Yanagawa H, Kawasaki T. Kawasaki disease in families. Pediatrics. 1989;84:666-669.
23. Harada F, Sada M, Kamiya T, Yanase Y, Kawasaki T, Sasazuki T. Genetic analysis of Kawasaki syndrome. Am J Hum Genet. 1986;39:537-539.
24. Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis. 2005;9:185-194.
25. Patriarca PA, Rogers MF, Morens DM, Schonberger LB, Kaminski RM, Burns JC, Glode MP. Kawasaki syndrome: association with the application of rug shampoo. Lancet. 1982;2:578-580.
26. Rauch AM, Kaplan SL, Nihill MR, Pappas PG, Hurwitz ES, Schonberger LB. Kawasaki syndrome clusters in Harris County, Texas, and eastern North Carolina: a high endemic rate and a new environmental risk factor. Am J Dis Child. 1988;142:441-444.
27. Ichida F, Fatica NS, O'Loughlin JE, Klein AA, Snyder MS, Levin AR, Ehlers KH, Lesser ML, Engle MA. Epidemiologic aspects of Kawasaki disease in a Manhattan hospital. Pediatrics. 1989;84:235-241.
28. Rowley AH, Shulman ST. New developments in the search for the etiologic agent of Kawasaki disease. Curr Opin Pediatr. 2007;19:71-74.
29. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DY. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A. 1992;89:4066-4070.
30. Curtis N, Zheng R, Lamb JR, Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child. 1995;72:308-311.
31. Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol. 1995;155:5018-5021.
32. Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, Myones BL, Wheeler JG, Ruthazer R, Schlievert PM. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr. 2002;140:742-746.
33. Terai M, Miwa K, Williams T, Kabat W, Fukuyama M, Okajima Y, Igarashi H, Shulman ST. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis. 1995;172:558-561.
34. Rowley AH, Baker SC, Shulman ST, Garcia FL, Guzman-Cottrill JA, Chou P, Terai M, Kawasaki T, Kalelkar MB, Crawford SE. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis. 2004;190:856-865.
35. Rowley AH, Baker SC, Shulman ST, Fox LM, Takahashi K, Garcia FL, Crawford SE, Chou P, Orenstein JM. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis. 2005;192:1757-1766.
36. Rowley AH, Shulman ST, Garcia FL, Guzman-Cottrill JA, Miura M, Lee HL, Baker SC. Cloning the arterial IgA antibody response during acute Kawasaki disease. J Immunol. 2005;175:8386-8391.
37. Kato S, Kimura M, Tsuji K, Kusakawa S, Asai T, Juji T, Kawasaki T. HLA antigens in Kawasaki disease. Pediatrics. 1978;61:252-255.
38. Barron KS, Silverman ED, Gonzales JC, St Clair M, Anderson K, Reveille JD. Major histocompatibility complex class II alleles in Kawasaki syndrome: lack of consistent correlation with disease or cardiac involvement. J Rheumatol, 1992;19:1790-1793.
39. Huang Y, Lee YJ, Chen MR, Hsu CH, Lin SP, Sung TC, Chang SC, Chang JG. Polymorphism of transmembrane region of MICA gene and Kawasaki disease. Exp Clin Immunogenet. 2000;17:130-137.
40. Ouchi K, Suzuki Y, Shirakawa T, Kishi F. Polymorphism of SLC11 A1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease. J Infect Dis. 2003;187:326-329.
41. Miura M, Garcia FL, Crawford SE, Rowley AH. Cell adhesion molecule expression in coronary artery aneurysms in acute Kawasaki disease. Pediatr Infect Dis J. 2004;23:931-936.
42. Takeshita S, Dobashi H, Nakatani K, Koike Y, Tsujimoto H, Hirayama K, Kawamura Y, Mod K, Sekine I, Yoshioka S. Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol. 1997;108:446-450.
43. Furui J, Ishii M, Ikeda H, Muta H, Egarai K, Sugahara Y, Himeno W, Akagi T, Kato H, Matsuishi T. Soluble forms of the selectin family in children with Kawasaki disease: prediction for coronary artery lesions. Acta Paediatr. 2002;91:1183-1188.
44. Savage CO, Cooke SP. The role of the endothelium in systemic vasculitis. J Autoimmun. 1993;6:237-249.
45. Terai M, Jibiki T, Harada A, Terashima Y, Yasukawa K, Tateno S, Hamada H, Oana S, Niimi H, Matsushima K. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol. 1999;65:566-572.
46. Hamamichi Y, Ichida F, Yu X, Hirono KI, Uese KI, Hashimoto I, Tsubata S, Yoshida T, Futatani T, Kanegane H, Miyawaki T. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Pediatr Res. 2001;49:74-80.
47. Yasukawa K, Terai M, Shulman ST, Toyozaki T, Yajima S, Kohno Y, Rowley AH. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation. 2002;105:766-769.
48. Matsubara T, Ichiyama T, Furukawa S. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol. 2005;141:381-387.
49. Eberhard BA, Andersson U, Laxer RM, Rose V, Silverman ED. Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J. 1995;14:199-203.
50. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation. 2001;104:860-863.
51. Senzaki H, Kobayashi T, Nagasaka H, Nakano H, Kyo S, Yokote Y, Sasaki N. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy. Pediatr Res. 2003;53:983-988.
52. Gavin PJ, Crawford SE, Shulman ST, Garcia FL, Rowley AH. Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol. 2003;23:576-581.
53. Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child. 2006;91:847-851.
54. Rowley AH, Shulman ST, Mask CA, Finn LS, Terai M, Baker SC, Galliani CA, Takahashi K, Naoe S, Kalelkar MB, Crawford SE. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis. 2000;182:1183-1191.
55. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341-347.
56. Newburger JW, Takahashi M, Beiser AS, Bums JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-1639.
57. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics. 1995;96:1057-1061.
58. Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr. 1997;131:888-893.
59. Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Pediatrics. 2004;114:e689-e693.
60. Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP; Pediatric Heart Network Investigators. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007;356:663-675.
61. Williams RV, Wilke VM, Tani LY, Minich LL. Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics. 2002;109:E4.
62. Nakano M, Kamijo Y, Toyaoda M. Preventive effects of urinastatin for coronary artery aneurysm formation in Kawasaki disease. In: Kato H, ed. Kawasaki Disease: Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, 22-25 May 1995. New York, NY: Elsevier; 1995:364-371.
63. Zaitsu M, Hamasaki Y, Tashiro K, Matsuo M, Ichimaru T, Fujita I, Tasaki H, Miyazaki S. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis. 2000;181:1101-1109.
64. Furukawa S, Matsubara T, Umezawa Y, Motohashi T, Ino T, Yabuta K. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. Eur J Pediatr. 1994;153:663-667.
65. Zulian F, Zanon G, Martini G, Mescoli G, Milanesi O. Efficacy of infliximab in long-lasting refractory Kawasaki disease. Clin Exp Rheumatol. 2006;24:453.
66. Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr. 2005;146:662-667.
67. Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS. Infliximab as a novel therapy for refractory Kawasaki disease. J Rheumatol. 2004;31:808-810.
68. Kuijpers TW, Biezeveld M, Achterhuis A, Kuipers I, Lam J, Hack CE, Becker AE, van der Waal AC. Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect. Pediatrics. 2003;112:986-992.
69. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics. 2000;105:E78.
70. Raman V, Kim J, Sharkey A, Chaula T. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy. Pediatr Infect Dis J. 2001;20:635-637.
71. Mon M, Imagawa T, Katakura S, Miyamae T, Okuyama K, Ito S, Nakamura T, Kimura H, Yokota S. Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin. Mod Rheumatol. 2004;14:43-47.
72. Takagi N, Kihara M, Yamaguchi S, Tamura K, Yabana M, Tokita Y, Ishii M. Plasma exchange in Kawasaki disease. Lancet. 1995;346:1307.
73. Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, New-burger JW, Parekh RS, Steinberger J; American Heart Association Expert Panel on Population and Prevention Science; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Nutrition, Physical Activity and Metabolism; American Heart Association Council on High Blood Pressure Research; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on the Kidney in Heart Disease; Interdisciplinary Working Group on Quality of Care and Outcomes Research. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006;114:2710-2738.
74. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379-1385.
75. Suzuki A, Kamiya T, Tsuda E, Tsukano S. Natural history of coronary artery lesion in Kawasaki disease. Prog Pediatr Cardiol. 1997;6:212-218.
76. Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, Kiyosawa N. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circ J. 2005;69:265-272.
77. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol. 1996;28:253-257.
78. Suzuki A, Miyagawa-Tomita S, Nakazawa M, Yutani C. Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings. Jpn Heart J. 2000;41:245-256.
79. Tsuda E, Kamiya T, Ono Y, Kimura K, Echigo S. Dilated coronary arterial lesions in the late period after Kawasaki disease. Heart. 2005;91:177-182.
80. Mok GC, Sung RY, Yam MC, Arifi AA, Lam WW, Fok TF. A child with Kawasaki disease who survived after rupture of a coronary artery aneurysm. Eur J Pediatr. 2003;162:634-636.
81. Hwong TM, Arifi AA, Wan IY, Thung KH, Wan S, Sung RY, Yim AP. Rupture of a giant coronary artery aneurysm due to Kawasaki disease. Ann Thorac Surg. 2004;78:693-695.
82. Satoda M, Tatsukawa H, Katoh S. Sudden death due to rupture of coronary aneurysm in a 26-year-old man. Circulation. 1998;97:705-706.
83. Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol. 2001;22:138-142.
84. Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: a pathological study? J Pediatr. 1982;100:225-231.
85. Tanaka N, Naoe S, Masuda H, Ueno T. Pathological study of sequelae of Kawasaki disease (MCLS): with special reference to the heart and coronary arterial lesions. Acta Pathol Jpn. 1986;36:1513-1527.
86. Fujiwara T, Fujiwara H, Nakano H. Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy: quantitative analysis. Circulation. 1988;78:345-350.
87. Sugimura T, Kato H, Inoue O, Fukuda T, Sato N, Ishii M, Takagi J, Akagi T, Maeno Y, Kawano T. Intravascular ultrasound of coronary arteries in children: assessment of the wall morphology and the lumen after Kawasaki disease. Circulation. 1994;89:258-265.
88. Suzuki A, Yamagishi M, Kimura K, Sugiyama H, Arakaki Y, Kamiya T, Miyatake K. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol. 1996;27:291-296.
89. Iemura M, Ishii M, Sugimura T, Akagi T, Kato H. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart. 2000;83:307-311.
90. Tsuda E, Kamiya T, Kimura K, Ono Y, Echigo S. Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening. Pediatr Cardiol. 2002;23:9-14.
91. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, Nakazawa M. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation. 2000;101:2935-2941.
92. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nakazawa M, Fukaya T, Baba K, Yutani C. Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease. Pediatr Int. 2004;46:590-596.
93. Gold L, Sung J, Siebert J. Type I (RI), and type II (Rn) receptors for transforming growth factor-β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound repair. Am J Pathol. 1997;150:209-222.
94. Majack RA, Majesky MW, Goodman LV. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J Cell Biol. 1990;111:239-247.
95. Bussolino F. Small molecule approaches for promoting ischemic tissue vascularization. Circ Res. 2006;99:231-233.
96. Fukazawa R, Ikegam E, Watanabe M, Hajikano M, Kamisago M, Katsube Y, Yamauchi H, Ochi M, Ogawa S. Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence. Circ J. 2007;71:709-715.
97. Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, Tsutsumi T, Kato H. Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol. 1998;31:1074-1080.
98. Furuyama H, Odagawa Y, Katoh C, Iwado Y, Yoshinaga K, Ito Y, Noriyasu K, Mabuchi M, Kuge Y, Kobayashi K, Tamaki N. Assessment of coronary function in children with a history of Kawasaki disease using (15)O-water positron emission tomography. Circulation. 2002;105:2878-2884.
99. Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, Mabuchi M, Yoshinaga K, Kuge Y, Kobayashi K, Tamaki N. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr. 2003;142:149-154.
100. Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr. 1992;121:684-688.
101. Mitani Y, Okuda Y, Shimpo H, Uchida F, Hamanaka K, Aoki K, Sakurai M. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation. 1997;96:454-461.
102. Matsumura K, Okuda Y, Ito T, Hirano T, Takeda K, Yamaguchi M. Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall. Angiology. 1988;39:141-147.
103. Muzik O, Paridon SM, Singh TP, Morrow WR, Dayanikli F, DiCarli MF. Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography. J Am Coll Cardiol. 1996;28:757-762.
104. Kitamura S, Kawashima Y, Fujita T, Mori T, Oyama C. Aortocoronary bypass grafting in a child with coronary artery obstruction due to mucocutaneous lymph node syndrome. Circulation. 1976;53:1035-1040.
105. Kitamura S, Kawachi K, Harima R, Sakakibara T, Hirose H, Kawashima Y. Surgery for coronary heart disease due to mucocutaneous lymph node syndrome (Kawasaki disease). Am J Cardiol. 1983;51:444-448.
106. Suzuki A, Kamiya T, Ono Y, Okuno M, Yagihara T. Aortocoronary bypass surgery for coronary arterial lesions resulting from Kawasaki disease. J Pediatr. 1990;116:567-573.
107. Kitamura S, Kawachi K, Oyama C, Miyagi Y, Morita R, Koh Y, Kim K, Nishii T. Severe Kawasaki heart disease treated with an internal mammary artery graft in pediatric patients: a first successful report. J Thorac Cardiovasc Surg. 1985;89:860-866.
108. Kitamura S, Kameda Y, Seki T, Kawachi K, Endo M, Takeuchi Y, Kawasaki T, Kawashima Y. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease: a multicenter cooperative study. J Thorac Cardiovasc Surg. 1994;107:663-674.
109. Tsuda E, Kitamura S; Cooperative Study Group of Japan. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation. 2004;110(suppl II:II-61-II-66.
110. Tsuda E, Kitamura S, Kimura K, Kobayashi J, Miyazaki S, Echigo S, Yagihara T. Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease: comparison of early with recent results in small children. Am Heart J. 2007;153:995-1000.
111. Tsuda E, Fujita H, Yagihara T, Yamada O, Echigo S, Kitamura S. Competition between native flow and graft flow after coronary artery bypass grafting: impact on indications for coronary artery bypass grafting for localized stenosis with giant aneurysms due to Kawasaki disease. Pediatr Cardiol. 2008;29:266-270.
112. Kawachi K, Kitamura S, Seki T, Morita R, Kawata T, Hasegawa J, Kameda Y. Hemodynamics and coronary blood flow during exercise after coronary artery bypass grafting with internal mammary arteries in children with Kawasaki disease. Circulation. 1991;84:618-624.
113. Inoue T, Otaki M, Oku H, Fukuda T, Shinohara T. Follow-up study of coronary artery bypass grafting in patients with Kawasaki disease. Am Heart J. 2001;142:740-744.
114. Nishimura H, Sawada T, Azuma A, Kohno Y, Katsume H, Nakagawa M, Sakata K, Hamaoka K, Onouchi Z. Percutaneous transluminal coronary angioplasty in a patient with Kawasaki disease: a case report of an unsuccessful angioplasty. Jpn Heart J. 1992;33:869-873.
115. Ino T, Akimoto K, Ohkubo M, Nishimoto K, Yabuta K, Takaya J, Yamaguchi H. Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. Circulation. 1996;93:1709-1715.
116. Ogawa S, Fukazawa R, Ohkubo T. Silent myocardial ischemia in Kawasaki disease: evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing. Circulation. 1997;96:3384-3389.
117. Sugimura T, Yokoi H, Sato N, Akagi T, Kimura T, Iemura M, Nobuyoshi M, Kato M. Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease. Circulation. 1997;96:3928-3933.
118. Hijazi ZM, Smith JJ, Fulton DR. Stent implantation for coronary artery stenosis after Kawasaki disease. J Invasive Cardiol. 1997;9:534-536.
119. Hashmi A, Lazzam C, McCrindle BW, Benson LN. Stenting of coronary artery stenosis in Kawasaki disease. Catheter Cardiovasc Interv. 1999;46:333-336.
120. Peters TF, Parikh SR, Pinkerton CA. Rotational ablation and stent placement for severe calcific coronary artery stenosis after Kawasaki disease. Catheter Cardiovasc Interv. 2002;56:549-552.
121. Tsuda E, Miyazaki S, Yamada O, Takamuro M, Takekawa T, Echigo S. Percutaneous transluminal coronary rotational atherectomy for localized stenosis caused by Kawasaki disease. Pediatr Cardiol. 2006;27:447-453.
122. Ishii M, Ueno T, Akagi T, Baba K, Harada K, Hamaoka K, Kato H, Tsuda E, Uemura S, Saji T, Ogawa S, Echjgo S, Yamaguchi T, Kato H; Research Committee of Ministry of Health, Labour and Welfare, Study of Treatment and Long-Term Management in Kawasaki Disease. Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int. 2001;43:558-562.
123. Akagi T. Interventions in Kawasaki disease. Pediatr Cardiol. 2005;26:206-212.
124. Waki K, Baba K. Transcatheter polytetrafluoroethylene-covered stent implantation in a giant coronary artery aneurysm of a child with Kawasaki disease: a potential novel treatment. Catheter Cardiovasc Interv. 2006;68:74-77.
125. Ishii M, Ueno T, Ikeda H, Iemura M, Sugimura T, Furui J, Sugahara Y, Muta H, Akagi T, Nomura Y, Homma T, Yokoi H, Nobuyoshi M, Matsuishi T, Kato H. Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation. 2002;105:3004-3010.
126. Tateno S, Terai M, Niwa K, Jibiki T, Hamada H, Yasukawa K, Honda T, Oana S, Kohno Y. Alleviation of myocardial ischemia after Kawasaki disease by heparin and exercise therapy. Circulation. 2001;103:2591-2597.
127. Suzuki A, Kamiya T, Tsuchiya K, Sato I, Arakaki Y, Kohata T, Ono Y. Tricuspid and mitral regurgitation detected by color flow Doppler in the acute phase of Kawasaki disease. Am J Cardiol. 1988;61:386-390.
128. Akagi T, Kato H, Inoue O, Sato N, Imamura K. Valvular heart disease in Kawasaki syndrome: incidence and natural history. Am Heart J. 1990;120:366-372.
129. Gidding SS, Shulman ST, Ilbawi M, Crussi F, Duffy CE. Mucocutaneous lymph node syndrome (Kawasaki disease): delayed aortic and mitral insufficiency secondary to active valvulitis. J Am Coll Cardiol. 1986;7:894-897.
130. Fukunaga S, Egashira A, Arinaga K, Akasu I, Kai E, Higashi T, Kosuga K, Aoyagi S, Kazue T. Aortic valve replacement for aortic regurgitation due to Kawasaki disease: report of two cases. J Heart Valve Dis. 1996;5:231-234.
131. Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, Sumitomo N, Harada K. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics. 2001;107:1095-1099.
132. Cheung YF, Wong SJ, Ho MH. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child. 2007;92:43-47.
133. Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol. 2004;43:120-124.
134. Senzaki H, Chen CH, Ishido H, Masutani S, Matsunaga T, Taketazu M, Kobayashi T, Sasaki N, Kyo S, Yokote Y. Arterial hemodynamics in patients after Kawasaki disease. Circulation. 2005;111:2119-2125.
135. Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, Dillon MJ, Deanfield JE. Endothelial dysfunction late after Kawasaki disease. Circulation. 1996;94:2103-2106.
136. Ooyanagi R, Fuse S, Tomita H, Takamuro M, Horita N, Mon M, Tsutsumi H. Pulse wave velocity and ankle brachial index in patients with Kawasaki disease. Pediatr Int. 2004;46:398-402.
137. McCrindle BW, McIntyre S, Kim C, Lin T, Adeli K. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis.' J Pediatr. 2007;151:244-248.
138. Silva AA, Maeno Y, Hashmi A, Smallhorn JF, Silverman ED, McCrindle BW. Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr. 2001;138:400-405.
139. Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int. 2005;47:711-732.
140. Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, Klein N, Booy R, Levin M, Dillon MJ. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child. 2002;86:286-290.
141. Suzuki A, Takemura A, Inaba R, Sonobe T, Tsuchiya K, Korenaga T. Magnetic resonance coronary angiography to evaluate coronary arterial lesions in patients with Kawasaki disease. Cardiol Young. 2006;16:563-571.
142. Tsuda E, Hanatani A, Kurosaki K, Naito H, Echigo S. Two young adults who had acute coronary syndrome after regression of coronary aneurysms caused by Kawasaki disease in infancy. Pediatr Cardiol. 2006;27:372-375.
143. Nakamura Y, Aso E, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Yanagawa H, Kawasaki T. Mortality among persons with a history of Kawasaki disease in Japan: can paediatricians safely discontinue follow-up of children with a history of the disease but without cardiac sequelae? Acta Paediatr. 2005;94:429-434.
144. McMorrow Tuohy AM, Tani LY, Cetta F, Lewin MB, Eidem BW. Van Buren P, Williams RV, Shaddy RE, Tuohy RP, Minich LL. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease? Am J Cardiol. 2001;88:328-330.
145. Scott JS, Ettedgui JA, Neches WH. Cost-effective use of echocardiography in children with Kawasaki disease. Pediatrics. 1999;104:e57.
146. Nolan TE, Savage RW. Peripartum myocardial infarction from presumed Kawasaki's disease. South Med J. 1990;83:1360-1361.
147. Arakawa K, Akita T, Nishizawa K, Kurita A, Nakamura H, Yoshida T, Kuroda K, Nagata I. Anticoagulant therapy during successful pregnancy and delivery in a Kawasaki disease patient with coronary aneurysm: a case report. Jpn Circ J. 1997;61:197-200.
148. Shear R, Leduc L. Successful pregnancy following Kawasaki disease. Obstet Gynecol. 1999;94:841.
149. Tsuda E, Ishihara Y, Kawamata K, Tsukano S, Negi R, Echigo S, Chiba Y. Pregnancy and delivery in patients with coronary artery lesions caused by Kawasaki disease. Heart. 2005;91:1481-1482.
150. Tsuda E, Kawamata K, Neki R, Echigo S, Chiba Y. Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan. Cardiol Young. 2006;16:173-178.
151. Harman SM. Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Gend Med. 2006;3:254-269.